Review



standard recombinant human β galactosidase 1 rhglb1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems standard recombinant human β galactosidase 1 rhglb1
    Standard Recombinant Human β Galactosidase 1 Rhglb1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/standard+recombinant+human+%CE%B2+galactosidase+1+rhglb1/Recombinant+Human+beta-Galactosidase-1%2FGLB1+Protein%2C+CF/pm41785816-91-49-54
    Average 94 stars, based on 4 article reviews
    standard recombinant human β galactosidase 1 rhglb1 - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Generated:

    Article Title: Placenta tissue-based and circulating markers of cellular senescence in gestational diabetes mellitus.
    Article Snippet: Background: Cellular senescence is an important pathophysiological feature in placenta-related pregnancy complications, but its role in gestational diabetes mellitus is not established.. Our aim was to examine histomorphological features, as well as immunohistochemical and circulating markers of senescence in placentas and plasma from women with gestational diabetes compared to euglycemic controls.. Methods: Normotensive women (gestational diabetes: n = 20; gestational age-matched euglycemic controls: n = 20) with placenta and third trimester plasma samples were included.

    Concentration Assay:

    Article Title: Placenta tissue-based and circulating markers of cellular senescence in gestational diabetes mellitus.
    Article Snippet: Background: Cellular senescence is an important pathophysiological feature in placenta-related pregnancy complications, but its role in gestational diabetes mellitus is not established.. Our aim was to examine histomorphological features, as well as immunohistochemical and circulating markers of senescence in placentas and plasma from women with gestational diabetes compared to euglycemic controls.. Methods: Normotensive women (gestational diabetes: n = 20; gestational age-matched euglycemic controls: n = 20) with placenta and third trimester plasma samples were included.

    Software:

    Article Title: Placenta tissue-based and circulating markers of cellular senescence in gestational diabetes mellitus.
    Article Snippet: Background: Cellular senescence is an important pathophysiological feature in placenta-related pregnancy complications, but its role in gestational diabetes mellitus is not established.. Our aim was to examine histomorphological features, as well as immunohistochemical and circulating markers of senescence in placentas and plasma from women with gestational diabetes compared to euglycemic controls.. Methods: Normotensive women (gestational diabetes: n = 20; gestational age-matched euglycemic controls: n = 20) with placenta and third trimester plasma samples were included.

    Clinical Proteomics:

    Article Title: Placenta tissue-based and circulating markers of cellular senescence in gestational diabetes mellitus.
    Article Snippet: Background: Cellular senescence is an important pathophysiological feature in placenta-related pregnancy complications, but its role in gestational diabetes mellitus is not established.. Our aim was to examine histomorphological features, as well as immunohistochemical and circulating markers of senescence in placentas and plasma from women with gestational diabetes compared to euglycemic controls.. Methods: Normotensive women (gestational diabetes: n = 20; gestational age-matched euglycemic controls: n = 20) with placenta and third trimester plasma samples were included.

    Recombinant:

    Article Title: Placenta tissue-based and circulating markers of cellular senescence in gestational diabetes mellitus.
    Article Snippet: Background: Cellular senescence is an important pathophysiological feature in placenta-related pregnancy complications, but its role in gestational diabetes mellitus is not established.. Our aim was to examine histomorphological features, as well as immunohistochemical and circulating markers of senescence in placentas and plasma from women with gestational diabetes compared to euglycemic controls.. Methods: Normotensive women (gestational diabetes: n = 20; gestational age-matched euglycemic controls: n = 20) with placenta and third trimester plasma samples were included.



    Similar Products

    94
    R&D Systems standard recombinant human β galactosidase 1 rhglb1
    Standard Recombinant Human β Galactosidase 1 Rhglb1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/standard+recombinant+human+%CE%B2+galactosidase+1+rhglb1/Recombinant+Human+beta-Galactosidase-1%2FGLB1+Protein%2C+CF/pm41785816-91-49-54
    Average 94 stars, based on 1 article reviews
    standard recombinant human β galactosidase 1 rhglb1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results